Based on the results of TIMER online tool and enrichment analysis above, FGFR4 deficiency might regulate the TIME by activating of the antigen presentation process and cellular immunity to the change in the sensitivity to ICIs treatment in NSCLC. Here, FGFR4 is linked to non-small cell lung carcinoma.